Category: Cancer Treatment
Europe Cancer Treatment
-
Germany Cancer Monoclonal Antibody Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Germany market. Also, factors that are driving and restraining the cancer monoclonal antibody market are highlighted in the study. ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Disease, and Other Disease Indication), Route of Administration (Intravenous, Subcutaneous, and Others), Drug Class (Granulocyte Colony-Stimulating Factor, Insulin, TNF Blockers and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region
... and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 ... Read More
-
Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global cancer biomarkers market is poised for significant growth and expansion in the upcoming years. Cancer biomarkers play a crucial role in early detection, diagnosis, and cancer monitoring applications by indicating the presence of cancer ... Read More
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Europe Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Breast cancer is the leading form of cancer affecting women in Europe, with approximately 400,000 new cases annually and resulting in 100,000 fatalities. This type of cancer originates from malignant tumors that develop in breast ... Read More
-
Europe Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... 2028, according to Renub Research. Within Europe, cervical cancer stands as the ninth most prevalent form of cancer affecting women, and it is the second leading cause of cancer-related deaths among women aged 15 to ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Germany Skin Cancer Diagnostics Market Forecast 2023-2030
... melanoma incidence, mandatory skin cancer screening, and substantial healthcare expenditure. MARKET INSIGHTS Data from the cancer registries of the Saarland and Schleswig-Holstein federal states in Germany underscore the rising incidence and mortality trends associated with ... Read More
-
Europe Skin Cancer Diagnostics Market Forecast 2023-2032
... measures, educational initiatives, and public health campaigns undertaken by individuals and healthcare providers. MARKET INSIGHTS Belgium, Poland, Italy, Nordic Countries, Germany, Spain, France, the United Kingdom, and Rest of Europe are assessed for the Europe ... Read More
-
United Kingdom (UK) Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030
... Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Procedures Using Implantable Ports. The databook report provides procedure volumes within segments - Implantable Ports Placed for Chemotherapy Treatments ... Read More
-
Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibr
... GlobalData’s “Spain Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Italy Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Italy Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Italy Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
EU5 Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroi
... GlobalData’s “EU5 Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the EU5 Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Germany Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Germany Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Germany Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “France Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
... 2030 Summary GlobalData’s “United Kingdom Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Embolization Particle Procedures. The databook report provides procedure volumes within segments ... Read More
-
France Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the France market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More
-
Molecular Cytogenetics Market, By Product Type (Instruments, Consumables, Software and Services), By Technology (FISH, aCGH), By Application (Genetic Disorder, Cancer, Personalized Medicine, Others.), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of ... Read More
-
HER-2 Negative Breast Cancer Market, By Type of Treatment (Chemotherapy, Radiation, Hormonal Therapy, and Other Types of Treatments) and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Outlook, and Opportunity Analysis, 2023 - 2030 HER2-negative negative breast cancer means that the cancerous cells do not contain high levels of the protein HER2. Cancer cells that are HER2 negative may grow more slowly ... Read More
-
Cancer Supportive Care Products Market, By Drug Class (Nonsteroidal Anti – Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor), By Indication(Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, ... Read More
-
2023 Hungary Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
-
2023 France Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in ... Read More
Research Assistance
